跳至主要内容
临床试验/JPRN-jRCT2080220485
JPRN-jRCT2080220485未知3 期

A study to investigate the preventive effect of AG-1749 against the onset of gastric and duodenal ulcers that can be seen during long-term treatment with nonsteroidal anti-inflammatory drugs (NSAID).

Takeda Pharmaceutical Company Limited0 个研究点目标入组 602 人开始时间: 2007年12月13日最近更新:

试验速览

阶段
3 期
入组人数
602

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1) The patient was on NSAID treatment on the day when consent was obtained, and requires the long-term continuous treatment even after treatment with the investigational drug is started.
  • 2) The patient was confirmed to have a history of gastric
  • ulcer or duodenal ulcer (combined gastric and duodenal
  • ulcer is also possible).

排除标准

  • 未提供

研究者

相似试验